-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on AVITA Medical, Raises Price Target to $22

Benzinga·11/12/2026 14:28:09
Diffusion vocale
TD Cowen analyst Joshua Jennings maintains AVITA Medical (NASDAQ:RCEL) with a Buy and raises the price target from $20 to $22.